EE05385B1 - LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon - Google Patents
LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioonInfo
- Publication number
- EE05385B1 EE05385B1 EEP200300381A EEP200300381A EE05385B1 EE 05385 B1 EE05385 B1 EE 05385B1 EE P200300381 A EEP200300381 A EE P200300381A EE P200300381 A EEP200300381 A EE P200300381A EE 05385 B1 EE05385 B1 EE 05385B1
- Authority
- EE
- Estonia
- Prior art keywords
- ákuiáhiváprotease
- áamino
- useunited
- sulphonamides
- benzothiazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01200529 | 2001-02-14 | ||
US28775801P | 2001-05-02 | 2001-05-02 | |
PCT/EP2002/001788 WO2002083657A2 (fr) | 2001-02-14 | 2002-02-14 | Sulfamides de 2-amino-benzothiazole substitue en tant qu'inhibiteurs de la protease du vih a large spectre |
Publications (2)
Publication Number | Publication Date |
---|---|
EE200300381A EE200300381A (et) | 2003-12-15 |
EE05385B1 true EE05385B1 (et) | 2011-02-15 |
Family
ID=26076833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300381A EE05385B1 (et) | 2001-02-14 | 2002-02-14 | LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon |
Country Status (31)
Country | Link |
---|---|
US (1) | US7659404B2 (fr) |
EP (1) | EP1370543B1 (fr) |
JP (1) | JP4530612B2 (fr) |
KR (1) | KR100870184B1 (fr) |
CN (2) | CN100369904C (fr) |
AP (1) | AP1504A (fr) |
AT (1) | ATE343567T1 (fr) |
AU (1) | AU2002302363B2 (fr) |
BG (1) | BG66301B1 (fr) |
BR (1) | BR0207862A (fr) |
CA (1) | CA2438304C (fr) |
CY (1) | CY1108073T1 (fr) |
CZ (1) | CZ304273B6 (fr) |
DE (1) | DE60215623T2 (fr) |
DK (1) | DK1370543T3 (fr) |
EA (1) | EA006096B1 (fr) |
EE (1) | EE05385B1 (fr) |
ES (1) | ES2275866T3 (fr) |
HK (1) | HK1061233A1 (fr) |
HR (1) | HRP20030735B1 (fr) |
HU (1) | HU229224B1 (fr) |
IL (2) | IL157171A0 (fr) |
MX (1) | MXPA03007236A (fr) |
NO (1) | NO326174B1 (fr) |
NZ (1) | NZ527391A (fr) |
PL (1) | PL213327B1 (fr) |
PT (1) | PT1370543E (fr) |
SI (1) | SI1370543T1 (fr) |
SK (1) | SK287582B6 (fr) |
WO (1) | WO2002083657A2 (fr) |
ZA (1) | ZA200306086B (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE302287T1 (de) | 1999-05-28 | 2005-09-15 | Virco Nv | Neue mutationsprofile der hiv-1 reverse transcriptase in verbindung mit phänotypischem medikamentresistenz |
EP1356082A2 (fr) | 2000-10-20 | 2003-10-29 | Virco Bvba | Nouveaux profils mutationnels de la transcriptase inverse du vih-1 en corr lation avec une r sistance ph notypique aux m dicaments |
CN100369904C (zh) | 2001-02-14 | 2008-02-20 | 泰博特克药品有限公司 | 2-(取代-氨基)-苯并噻唑磺酰胺hiv蛋白酶抑制剂 |
EP1483254A4 (fr) | 2002-01-07 | 2005-06-08 | Sequoia Pharmaceuticals | Inhibiteurs de protease retrovirale anti-resistance |
US7157489B2 (en) | 2002-03-12 | 2007-01-02 | The Board Of Trustees Of The University Of Illinois | HIV protease inhibitors |
CA2490862A1 (fr) | 2002-07-01 | 2004-01-08 | Tibotec Pharmaceuticals Ltd. | Nouveaux profils mutationnels dans une protease du vih-1 correles a une resistance phenotypique aux medicaments |
AU2003251732B2 (en) | 2002-07-01 | 2008-09-18 | Tibotec Pharmaceuticals Ltd. | New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance |
AP1878A (en) * | 2002-08-02 | 2008-08-13 | Tibotec Pharm Ltd | Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors. |
OA12893A (en) * | 2002-08-02 | 2006-10-13 | Tibotec Pharm Ltd | Broadspectrum 2-Amino-Benzothiazole Sulfonamide HIV Protease Inhibitors. |
EA011891B1 (ru) * | 2003-09-30 | 2009-06-30 | Тиботек Фармасьютикалз Лтд. | Способы получения соединений бензоксазолсульфонамида и их промежуточные соединения |
DE10360835A1 (de) * | 2003-12-23 | 2005-07-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel |
AU2005244121B2 (en) * | 2004-05-07 | 2012-01-19 | Sequoia Pharmaceuticals, Inc. | Resistance-repellent retroviral protease inhibitors |
KR101333627B1 (ko) | 2005-02-25 | 2013-11-27 | 얀센 알 앤드 디 아일랜드 | 프로테아제 저해제 전구체 합성 |
AR053845A1 (es) | 2005-04-15 | 2007-05-23 | Tibotec Pharm Ltd | 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450 |
JO2841B1 (en) * | 2006-06-23 | 2014-09-15 | تيبوتيك فارماسيوتيكالز ليمتد | 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV) |
WO2011061590A1 (fr) | 2009-11-17 | 2011-05-26 | Hetero Research Foundation | Nouveaux dérivés carboxamides comme inhibiteurs du vih |
JO3090B1 (ar) * | 2009-12-11 | 2017-03-15 | Janssen Sciences Ireland Uc | 5- امينو-4- هيدروكسي-بنتويل اميدات |
US9024038B2 (en) | 2010-12-27 | 2015-05-05 | Purdue Research Foundation | Compunds and methods for treating HIV |
PE20141558A1 (es) | 2012-04-20 | 2014-11-06 | Gilead Sciences Inc | Derivados de acido benzotiazol-6-il acetico y su uso para tratar una infeccion por vih |
CN104000824B (zh) * | 2014-05-28 | 2016-07-06 | 中山大学 | 苯并五元杂环类化合物在制备抗hiv-1病毒药物中的应用 |
US11439608B2 (en) | 2017-09-25 | 2022-09-13 | Qun Lu | Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE141635T1 (de) | 1990-03-09 | 1996-09-15 | Milliken Res Corp | Organische materialien, die sulfonamidogebundene poly(oxyalkylen)gruppen tragen und ihre herstellung |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
KR100336699B1 (ko) | 1992-08-25 | 2002-05-13 | 윌리암스 로저 에이 | 레트로바이러스 프로테아제 저해제로서 유용한히드록시에틸아미노 술폰아미드 |
PH30929A (en) | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
IS2334B (is) | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
EP0715618B1 (fr) | 1993-08-24 | 1998-12-16 | G.D. Searle & Co. | Hydroxyethylamino-sulfonamides aptes a etre utilises comme inhibiteurs de protease retrovirale |
DE69429357T2 (de) | 1993-10-01 | 2002-08-14 | Astrazeneca Ab, Soedertaelje | Verfahren i |
CA2210889C (fr) | 1995-01-20 | 2007-08-28 | G.D. Searle & Co. | Inhibiteurs hydroxyethylamino contenant des bis-sulfinamides utilises pour inhiber des proteases retrovirales |
US6140505A (en) | 1995-03-10 | 2000-10-31 | G. D. Searle & Co. | Synthesis of benzo fused heterocyclic sulfonyl chlorides |
US5756533A (en) * | 1995-03-10 | 1998-05-26 | G.D. Searle & Co. | Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
US5705500A (en) | 1995-03-10 | 1998-01-06 | G.D. Searle & Co. | Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
US6150556A (en) * | 1995-03-10 | 2000-11-21 | G. D. Dearle & Co. | Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
US6861539B1 (en) * | 1995-03-10 | 2005-03-01 | G. D. Searle & Co. | Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
US6143788A (en) * | 1995-03-10 | 2000-11-07 | G.D. Searle & Co. | Bis-amino acid hydroxyethlamino sulfonamide retroviral protease inhibitors |
DE69625183T2 (de) | 1995-03-10 | 2003-10-09 | G.D. Searle & Co., Chicago | Heterocyclocarbonyl-aminosäure-hydroxyethylamino-sulfonamid inhibitoren retroviraler proteasen |
AU7722296A (en) | 1995-11-15 | 1997-06-05 | G.D. Searle & Co. | Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
HU227745B1 (en) | 1996-05-20 | 2012-02-28 | Janssen Pharmaceutica Nv | Antifungal compositions containing itraconazole |
BR9806174A (pt) | 1997-03-26 | 1999-10-19 | Janssen Pharmaceutica Nv | Péletes tendo um núcleo revestido com um antifúngico e um polìmero |
US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
AU2010299A (en) | 1997-12-24 | 1999-07-19 | Vertex Pharmaceuticals Incorporated | Prodrugs os aspartyl protease inhibitors |
WO1999033795A1 (fr) | 1997-12-24 | 1999-07-08 | Vertex Pharmaceuticals Incorporated | Promedicaments de la classe des inhibiteurs d'aspartyle protease |
TR200002402T2 (tr) | 1997-12-24 | 2001-01-22 | Vertex Pharmaceuticals Incorporated | Aspartil proteaz inhibitörü ön-ilaçlar. |
OA11573A (en) | 1998-06-19 | 2004-07-01 | Vertex Pharma | Sulfonamide inhibitors of aspartyl protease. |
AU4828199A (en) | 1998-06-23 | 2000-01-10 | Board Of Trustees Of The University Of Illinois, The | Multi-drug resistant retroviral protease inhibitors and associated methods |
PT2336134T (pt) | 1998-06-23 | 2016-10-19 | The Board Of Trustees Of The Univ Of Illionis | Ensaio de aptidão e métodos para reduzir a resistência do hiv à terapia |
AR031520A1 (es) | 1999-06-11 | 2003-09-24 | Vertex Pharma | Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion |
CN100369904C (zh) | 2001-02-14 | 2008-02-20 | 泰博特克药品有限公司 | 2-(取代-氨基)-苯并噻唑磺酰胺hiv蛋白酶抑制剂 |
-
2002
- 2002-02-14 CN CNB028049829A patent/CN100369904C/zh not_active Expired - Fee Related
- 2002-02-14 CN CN2007101997173A patent/CN101230067B/zh not_active Expired - Fee Related
- 2002-02-14 PL PL363778A patent/PL213327B1/pl unknown
- 2002-02-14 DE DE60215623T patent/DE60215623T2/de not_active Expired - Lifetime
- 2002-02-14 KR KR1020037010506A patent/KR100870184B1/ko not_active IP Right Cessation
- 2002-02-14 EE EEP200300381A patent/EE05385B1/xx not_active IP Right Cessation
- 2002-02-14 MX MXPA03007236A patent/MXPA03007236A/es active IP Right Grant
- 2002-02-14 AU AU2002302363A patent/AU2002302363B2/en not_active Ceased
- 2002-02-14 BR BR0207862-7A patent/BR0207862A/pt not_active IP Right Cessation
- 2002-02-14 JP JP2002581413A patent/JP4530612B2/ja not_active Expired - Fee Related
- 2002-02-14 ES ES02729930T patent/ES2275866T3/es not_active Expired - Lifetime
- 2002-02-14 SI SI200230467T patent/SI1370543T1/sl unknown
- 2002-02-14 HU HU0303257A patent/HU229224B1/hu not_active IP Right Cessation
- 2002-02-14 NZ NZ527391A patent/NZ527391A/xx not_active IP Right Cessation
- 2002-02-14 EA EA200300891A patent/EA006096B1/ru not_active IP Right Cessation
- 2002-02-14 AP APAP/P/2003/002856A patent/AP1504A/en active
- 2002-02-14 IL IL15717102A patent/IL157171A0/xx unknown
- 2002-02-14 WO PCT/EP2002/001788 patent/WO2002083657A2/fr active IP Right Grant
- 2002-02-14 AT AT02729930T patent/ATE343567T1/de active
- 2002-02-14 PT PT02729930T patent/PT1370543E/pt unknown
- 2002-02-14 US US10/467,609 patent/US7659404B2/en not_active Expired - Fee Related
- 2002-02-14 CZ CZ2003-2415A patent/CZ304273B6/cs not_active IP Right Cessation
- 2002-02-14 CA CA2438304A patent/CA2438304C/fr not_active Expired - Fee Related
- 2002-02-14 DK DK02729930T patent/DK1370543T3/da active
- 2002-02-14 EP EP02729930A patent/EP1370543B1/fr not_active Expired - Lifetime
- 2002-02-14 SK SK1102-2003A patent/SK287582B6/sk not_active IP Right Cessation
-
2003
- 2003-07-30 IL IL157171A patent/IL157171A/en not_active IP Right Cessation
- 2003-08-06 ZA ZA2003/06086A patent/ZA200306086B/en unknown
- 2003-08-13 NO NO20033584A patent/NO326174B1/no not_active IP Right Cessation
- 2003-09-01 BG BG108143A patent/BG66301B1/bg unknown
- 2003-09-12 HR HR20030735A patent/HRP20030735B1/xx not_active IP Right Cessation
-
2004
- 2004-06-03 HK HK04104020A patent/HK1061233A1/xx not_active IP Right Cessation
-
2007
- 2007-01-25 CY CY20071100088T patent/CY1108073T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE05385B1 (et) | LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon | |
NO20033556D0 (no) | Farmasöytiske preparater | |
DK1478339T3 (da) | Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf | |
IS7714A (is) | Lyfjasamsetningar úr módafíníl | |
AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
NO20033384D0 (no) | Farmasöytisk formulering | |
NO20040356L (no) | Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling. | |
NO20033785D0 (no) | Farmasöytisk formulering | |
IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
NO20044192L (no) | 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater | |
NO20024528L (no) | Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen | |
NO20041272L (no) | Tetracycline derivatives and methods of use thereof | |
NO20040268L (no) | Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen | |
NO20044916L (no) | Preparater av sulfinylacetamid | |
NO20035627D0 (no) | Farmasöytisk formulering | |
NO20033854L (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
NO20035328D0 (no) | Nye forbindelser og preparater som katepsinhibitorer | |
NO20033506L (no) | Parasitticidale preparater og metoder for anvendelse | |
IS6956A (is) | Sítrat salt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9-pentaen og lyfjafræðilegar samsetningar af því | |
DK1387838T3 (da) | Cyanoanthranylamid-derivater og deres anvendelse som lægemidler | |
EE200300501A (et) | Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid | |
EE05384B1 (et) | LaiaspektrilisedÁ2-(asendatudÁamino)bensoksasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁkasutamine,ÁfarmatseutilineÁkompositsioonÁjaÁmeetodÁretroviiruseÁreplikatsiooniÁinhibeerimiseks | |
DK1407780T3 (da) | Farmaceutisk stabile hæmostatiske præparater | |
NO20041485L (no) | Farmasoytisk formulering omfattende (R)-bicalutamid | |
NO20033117D0 (no) | Farmasoytiske blandinger som inhiberer vaskulor proliferasjon og metoder for anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HE1A | Change of address | ||
HE1A | Change of address | ||
MM4A | Lapsed by not paying the annual fees |
Effective date: 20160214 |